{"filings":[{"id":2310797,"accession_number":"0001932393-26-000050","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2026-08-18T13:03:25+00:00","items":["5.02","9.01"],"status":"ready","headline":"GE HealthCare names William Grogan CFO effective Sept 14, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William Grogan appointed CFO effective Sept 14, 2026, succeeding Jay Saccaro who stepped down for outside role.","Grogan joins from Xylem (CFO since 2023); prior CFO at IDEX 2017-2023; base salary $900k, target bonus 100%.","Sign-on cash $550k (repayable if resigns within 2 yrs) plus $4M RSU sign-on equity vesting over 2 yrs.","Annual LTI target $3.3M; 2026 LTI award $3.3M with performance stock units and stock options vesting through 2029.","Interim CFO George Newcomb reverts to Controller and Chief Accounting Officer on Sept 14, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1922276,"accession_number":"0001932393-26-000047","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2026-07-29T10:27:49+00:00","items":["7.01","9.01"],"status":"ready","headline":"GE HealthCare combines Imaging and AVS into new Advanced Imaging Solutions segment; recasts historical financials","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New segment structure: AIS, Pharmaceutical Diagnostics (PDx), and Patient Care Solutions (PCS).","Q1 2026 recast: AIS revenue $3,640M, PDx $770M, PCS $704M; total revenue $5,131M.","Q1 2026 segment EBIT: AIS $479M, PDx $197M, PCS $10M; total segment EBIT $691M.","Full-year 2025 recast: AIS revenue $14,599M, PDx $2,900M, PCS $3,086M; total $20,625M.","Full-year 2025 segment EBIT: AIS $2,067M, PDx $872M, PCS $209M; total $3,155M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1922277,"accession_number":"0001932393-26-000045","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2026-07-29T10:25:46+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q2 revenue up 5.7% to $5.3B; EPS $1.24; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $5.3B (+5.7% YoY); organic revenue +3.5%; net income $561M vs $486M.","Diluted EPS $1.24 (+16.5%); adjusted EPS $1.13 (+6.6%).","Record organic orders growth 11.1%, book-to-bill 1.15x, backlog $23.9B.","Patient Care Solutions revenue -13.3%, EBIT -$26M; CEO reviewing strategic options.","Reaffirms FY2026 guidance: organic rev growth 3-4%, adj EPS $4.80-$5.00, FCF ~$1.6B."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1829916,"accession_number":"0001932393-26-000039","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2026-07-23T20:17:30+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"GE HealthCare CFO Saccaro resigns; preliminary Q2 revenue up 5.7%, EPS ahead of expectations","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Jay Saccaro resigns effective Aug 14, 2026; George Newcomb (Controller & CAO) named interim CFO.","Preliminary Q2 revenue growth 5.7% YoY; organic revenue growth 3.5%.","Adjusted EPS ahead of prior expectation; full-year 2026 guidance reaffirmed.","Complete Q2 results to be reported on July 29, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":14721,"accession_number":"0001932393-26-000034","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2026-05-11T20:51:39+00:00","items":["5.07","8.01"],"status":"ready","headline":"GE HealthCare shareholders elect 8 directors, appoint lead director and committee chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["All eight director nominees elected at May 7 annual meeting; Kevin A. Lobo received lowest support with 332M votes for.","Rodney F. Hochman appointed as independent lead director effective May 7, 2026.","Anne T. Madden appointed as chairperson of the Nominating and Governance Committee.","Advisory vote on executive compensation approved (351M for vs 13M against, 795K abstain).","Ratification of Deloitte & Touche as auditor for FY 2026 (398M for, 770K against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96787,"accession_number":"0001932393-26-000030","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2026-04-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q1 revenue up 7.4% but net income drops; cuts full-year guidance on inflation and tariffs","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $5.1B (+7.4% reported, +2.9% organic); net income $389M vs $564M; diluted EPS $0.85 vs $1.23; adjusted EPS $0.99 vs $1.01.","Adjusted EBIT margin 13.5% vs 15.0%, down 150 bps; FY guidance reduced to 15.4-15.7% (from 15.8-16.1%).","FY 2026 Adjusted EPS guidance cut to $4.80-$5.00 (from $4.95-$5.15); Free cash flow guides ~$1.6B (from ~$1.7B).","PDx supplier issue (now resolved), memory chip/oil/freight inflation, and tariffs hurt margins; no IEEPA tariff refund assumed.","Closed Intelerad acquisition for $2.3B; repurchased $100M in shares (1.4M shares) during quarter."],"consensus_eps_estimate":1.0708,"consensus_eps_actual":0.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":5131000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111024,"accession_number":"0001932393-26-000013","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2026-03-17T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"GE HealthCare appoints Kevin Lobo (Stryker CEO) to Board; two directors not re-standing","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kevin A. Lobo, Chair & CEO of Stryker (NYSE: SYK), appointed to GEHC Board effective March 13, 2026.","Lobo will serve on the Talent, Culture, and Compensation Committee.","Risa Lavizzo-Mourey and Tomislav Mihaljevic will not stand for re-election at 2026 annual meeting; no disagreement cited.","Lobo brings over 25 years of medtech leadership; appointment is immediate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111023,"accession_number":"0001932393-26-000010","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2026-02-27T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"GE HealthCare enters new $0.5B 364-day revolving credit facility, replacing prior facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $0.5B senior unsecured 364-day revolver matures February 25, 2027; replaces similarly sized 2025 facility terminated without penalty.","Interest rate options include ABR, daily simple SOFR, adjusted Term SOFR for USD; EURIBOR for EUR; SONIA for GBP; margin tied to credit ratings.","Covenants limit liens, fundamental changes, leverage ratio, and subsidiary indebtedness; standard events of default included.","JPMorgan Chase Bank serves as administrative agent; joint bookrunners include Citibank, BofA Securities, BNP Paribas, Goldman Sachs, Morgan Stanley."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111022,"accession_number":"0001932393-26-000006","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2026-02-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q4 revenue up 7.1% to $5.7B; 2026 EPS guidance $4.95-$5.15","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $5.7B (+7.1% YoY, organic +4.8%); diluted EPS $1.29, adjusted EPS $1.44.","Full year revenue $20.6B (+4.8%); diluted EPS $4.55, adjusted EPS $4.59; free cash flow $1.5B.","2026 guidance: organic revenue growth 3-4%, adj. EPS $4.95-$5.15, adj. EBIT margin 15.8-16.1%.","Q4 net income $589M vs $720M prior; margins compressed due to tariff expense and unfavorable mix.","Acquiring Intelerad for $2.3B, expected close H1 2026; closed Nihon Medi-Physics and icometrix in 2025."],"consensus_eps_estimate":1.4263,"consensus_eps_actual":4.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":20625000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127650,"accession_number":"0001193125-25-319383","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-12-15T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"GE HealthCare enters $750M term loan and issues $1.25B notes to fund Intelerad acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Term loan credit facility of $750 million, three-year, unsecured, with JPMorgan as administrative agent.","Issued $600M 4.150% Senior Notes due 2028 and $650M 4.950% Senior Notes due 2035.","Proceeds from notes, term loan, and cash on hand to pay purchase price for Intelerad Medical Systems.","Term loan interest based on base rate or SOFR plus margin tied to credit ratings; contains leverage covenant.","Notes are senior unsecured and rank equally with other unsecured debt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127649,"accession_number":"0001193125-25-305400","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-12-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"GE HealthCare prices $1.25B notes: $600M at 4.150% due 2028, $650M at 4.950% due 2035","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Priced $600M of 4.150% Notes due Dec 15, 2028 and $650M of 4.950% Notes due Dec 15, 2035.","Expected issuance on or around Dec 15, 2025, subject to customary closing conditions.","Underwriting agreement with Goldman Sachs & Co. LLC and BNP Paribas Securities Corp. as representatives.","Offering is an underwritten public offering pursuant to existing shelf registration statement (File No. 333-280584)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127648,"accession_number":"0001932393-25-000052","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q3 revenue up 6% to $5.1B; adjusted EPS down to $1.07 from $1.14; raises low end of FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $5.1B (+6% reported, +4% organic); organic orders +6% across all segments.","Net income $446M ($0.98 diluted EPS) vs $470M ($1.02); adjusted EPS $1.07 vs $1.14.","Segment EBIT margin declines: Imaging 10.2% (-260bps), Patient Care Solutions 3.7% (-680bps), Pharmaceutical Diagnostics 29.4% (-150bps).","Full-year adjusted EPS guidance low end raised to $4.51-$4.63 (prev $4.43-$4.63); organic revenue ~3% growth reaffirmed.","Management cites ~$265M tariff impact on adjusted EBIT and $0.45 on adjusted EPS; free cash flow $483M vs $651M prior year."],"consensus_eps_estimate":1.0717,"consensus_eps_actual":3.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":14927000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144429,"accession_number":"0001932393-25-000048","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q2 beats, raises FY guidance; adj. EPS $1.06, organic rev +2%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $5.0B, organic growth 2%; net income $486M vs $428M YoY.","Adjusted EPS $1.06 vs $1.00 YoY; cash from ops $94M vs ($119M) YoY.","Raises FY guidance: organic rev ~3%, adj. EBIT margin 15.2%-15.4%, adj. EPS $4.43-$4.63.","Segment highlights: Imaging EBIT margin 8.5% (-110bps), PD revenue +14%.","Tariff impact ~$0.45/share in updated guidance; new FCF target at least $1.4B."],"consensus_eps_estimate":0.936,"consensus_eps_actual":2.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":9784000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144428,"accession_number":"0001932393-25-000044","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-07-24T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Lloyd W. Howell, Jr. resigns from GE HealthCare board effective July 23, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lloyd W. Howell, Jr. resigned from the Board of Directors, effective immediately.","Resignation is not due to any disagreement with the Company's operations, policies, or practices.","No replacement has been announced at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162783,"accession_number":"0001932393-25-000041","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-06-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"GE HealthCare issues $650M 4.800% notes due 2031 and $850M 5.500% notes due 2035","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $650M of 4.800% Senior Notes due 2031 and $850M of 5.500% Senior Notes due 2035.","Interest on 2031 notes payable Jan 15 & Jul 15, starting Jan 15, 2026; 2035 notes payable Jun 15 & Dec 15, starting Dec 15, 2025.","Notes are senior unsecured obligations, rank equally with all other senior unsecured indebtedness including existing senior notes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162782,"accession_number":"0001932393-25-000039","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-06-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"GE HealthCare prices $1.5B notes offering: $650M 4.800% due 2031, $850M 5.500% due 2035","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Priced $650M aggregate principal of 4.800% Notes due Jan 15, 2031 and $850M of 5.500% Notes due Jun 15, 2035.","Expected closing on or about June 9, 2025, subject to customary closing conditions.","Underwriting led by Citigroup, J.P. Morgan, and Morgan Stanley as representatives.","Use of proceeds not disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162781,"accession_number":"0001932393-25-000032","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-05-30T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"GE HealthCare shareholders elect all 10 directors and approve say-on-pay at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 10 director nominees elected; Peter Arduini received ~357M votes for, 683K against.","Advisory vote on named executive officer compensation approved: 338M for, 19M against.","Deloitte & Touche ratified as auditor for FY 2025 with ~397M votes for.","Shareholder proposal on termination pay ratification rejected: ~335M against, 21M for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162780,"accession_number":"0001932393-25-000013","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"GE HealthCare Q1 EPS $1.23, adj EPS $1.01; guides 2025 lower; authorizes $1B buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4.8B (+3% reported, +4% organic); net income $564M vs $374M a year ago.","Diluted EPS $1.23 (adj $1.01) vs $0.81 (adj $0.90); free cash flow $98M vs $274M.","FY2025 guidance cut: adj EBIT margin 14.2-14.4% (prev 16.7-16.8%); adj EPS $3.90-4.10 (prev $4.61-4.75) citing tariffs.","Board authorized $1.0B share repurchase program with no expiration date.","Segment Imaging rev $2.14B (+4%), PDx rev $632M (+6%); total orders organic +10%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":4777000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180749,"accession_number":"0001932393-25-000007","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"GE HealthCare refinances credit facilities: $3.0B revolver and $0.5B 364-day facility replace prior agreements","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $3.0B revolving credit facility matures March 27, 2030; new $0.5B 364-day facility matures March 26, 2026.","Replaces prior $2.5B revolving facility (November 2022) and $1.0B 364-day facility (December 2024), both terminated March 27, 2025.","JPMorgan Chase Bank, N.A. named administrative agent (previously Citibank). Interest rate based on SOFR/EURIBOR/SONIA plus margin tied to credit ratings.","Covenants include limits on liens, fundamental changes, leverage ratio, and non-guarantor subsidiary indebtedness."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180748,"accession_number":"0001932393-25-000004","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2025-02-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare reports Q4 EPS $1.57, adjusted EPS $1.45; guides FY2025 adjusted EPS $4.61-$4.75","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $5.3B, up 2% organic; net income $720M (13.5% margin) vs $403M (7.7%).","Diluted EPS $1.57 vs $0.88; Adjusted EPS $1.45 vs $1.18; Adjusted EBIT margin 18.7% vs 16.1%.","FY2024 revenue $19.7B (+1% organic); net income $2.0B; diluted EPS $4.34; Adjusted EPS $4.49.","FY2025 guidance: organic revenue growth 2-3%; adjusted EBIT margin 16.7-16.8%; adjusted EPS $4.61-$4.75.","Segment highlights: Advanced Visualization Solutions (+4% organic) and Pharmaceutical Diagnostics (+9%) grew; China weakness noted."],"consensus_eps_estimate":null,"consensus_eps_actual":4.34,"consensus_revenue_estimate":null,"consensus_revenue_actual":19672000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197592,"accession_number":"0001193125-24-277089","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-12-12T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"GE HealthCare enters $1B 364-day revolving credit facility, replacing prior facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.0B senior unsecured revolving credit facility entered on Dec 11, 2024, maturing Dec 10, 2025.","Replaces $1.0B 364-day facility dated Dec 13, 2023, which matured on Dec 11, 2024.","Borrowings available in USD and Euros; interest at Term SOFR or EURIBOR plus margin based on credit ratings.","Includes customary covenants, leverage ratio limitation, and events of default; consistent with GEHC's five-year facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197591,"accession_number":"0001932393-24-000054","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-11-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"GE HealthCare increases quarterly dividend 17% and sets medium-term targets at 2024 Investor Day","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Quarterly cash dividend increased ~17%; no new per-share amount or dates stated in release.","Medium-term (2026-2028) targets: organic revenue growth 4-6%, adjusted EBIT margin high-teens to 20%+, adjusted EPS growth high-single to low-double digit, FCF conversion 90%+.","Reiterated 2024 outlook: organic revenue growth 1-2% trending lower end, adjusted EBIT margin 15.8-16.0%, adjusted EPS $4.25-$4.35, FCF ~$1.8B.","Company highlighted progress since spin-off and precision care strategy focused on AI, radiopharmaceuticals, and enterprise partnerships.","CEO Peter Arduini expressed confidence in growth pipeline; CFO Jay Saccaro cited margin expansion and disciplined capital allocation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197590,"accession_number":"0001193125-24-254226","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-11-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"GE HealthCare prices secondary offering of 13.3M shares; company gets no proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Secondary offering of 13,281,302 shares priced; GE HealthCare receives no proceeds.","Prior to offering, GE Aerospace exchanges shares for debt held by Morgan Stanley Bank.","Morgan Stanley & Co. LLC sells shares through underwriters; expected close Nov 12, 2024.","J.P. Morgan, Citigroup, and Morgan Stanley are joint book-running managers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197589,"accession_number":"0001932393-24-000051","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"GE HealthCare realigns IGT to AVS segment; recasts 2022-2024 segment revenue and EBIT","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Effective July 1, 2024, Image Guided Therapies moved from Imaging to Ultrasound, renamed Advanced Visualization Solutions (AVS).","Recast Q2 2024 Imaging revenue $2,171M; AVS revenue $1,249M (Procedural Guidance $668M, Specialized Ultrasound $581M).","Recast Q2 2024 Segment EBIT: Imaging $208M, AVS $255M, PCS $78M, PDx $200M.","Total revenue and EBIT unchanged; company now reports four segments: Imaging, AVS, PCS, PDx."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197588,"accession_number":"0001932393-24-000049","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q3 adj EPS $1.14, revenue $4.9B; raises FY margin and EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4.9B, +1% YoY reported and organic; orders +1% organically, book-to-bill 1.04x.","Adj EPS $1.14 vs $0.99; net income $470M; net margin 9.7% vs 7.8%; Adj EBIT margin 16.3%, +90bps.","Free cash flow $651M vs $570M; cash from ops $742M, +$92M YoY.","FY24 guidance: Adj EPS $4.25-4.35 (prev $4.20-4.35); Adj EBIT margin 15.8-16.0% (prev 15.7-16.0%).","China softness offsets US growth; PDx segment revenue +6% organic; Imaging flat."],"consensus_eps_estimate":null,"consensus_eps_actual":2.77,"consensus_revenue_estimate":null,"consensus_revenue_actual":14353000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213817,"accession_number":"0001193125-24-218963","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-09-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"GE HealthCare prices upsized secondary offering of 15M shares at $86; no proceeds to company","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Secondary offering upsized from 10M to 15M shares at $86.00/share; underwriters have option for 2.25M additional shares.","Selling stockholder Morgan Stanley & Co. LLC will sell shares after debt-for-equity exchange by GE Aerospace (General Electric).","GE HealthCare will not receive any proceeds from the offering or the exchange.","Offering expected to close September 16, 2024; Morgan Stanley and Citigroup are lead book-running managers.","Net proceeds from the sale will go to GE Aerospace (via debt exchange) and Morgan Stanley as selling stockholder."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213816,"accession_number":"0001193125-24-201356","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-08-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"GE HealthCare issues $1B of 4.800% notes due 2029","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1B aggregate principal amount of 4.800% Notes due August 14, 2029.","Interest payable semi-annually on Feb 14 and Aug 14, starting Feb 14, 2025.","Notes are senior unsecured obligations ranking equally with other senior unsecured debt.","Issued under base indenture and second supplemental indenture with Bank of New York Mellon as trustee.","Notes offered under effective shelf registration statement on Form S-3."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213815,"accession_number":"0001193125-24-197921","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-08-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"GE HealthCare prices $1B of 4.800% Notes due 2029","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1,000,000,000 aggregate principal of 4.800% Notes due August 14, 2029.","Underwriting led by Goldman Sachs, BofA Securities, and Morgan Stanley.","Offering priced on August 7, 2024; closing expected August 14, 2024.","Issued under existing shelf registration statement (File No. 333-280584)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213814,"accession_number":"0001932393-24-000043","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare reports Q2 2024: flat revenue, margin expansion, updates guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue flat at $4.8B; organic revenue grew 1% YoY; net income margin improved to 8.9% from 8.7%.","Adjusted EBIT margin expanded to 15.3% (up 60 bps); adjusted EPS rose to $1.00 from $0.92.","Full-year organic revenue growth guidance lowered to 1-2% (from ~4%) due to China headwinds; adjusted EBIT margin guidance raised to 15.7-16.0%.","Cash flow from operations was -$119M vs -$67M; free cash flow -$182M vs -$136M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":9489000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233032,"accession_number":"0001628280-24-024926","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-05-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"GE HealthCare stockholders elect all 10 directors at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 10 director nominees elected with substantial majority; Peter Arduini received 358M votes for.","Say-on-pay advisory vote approved: 332.6M for (93% of votes cast), 24.5M against.","Ratification of Deloitte & Touche as auditor for FY2024 passed with 399.4M for, 0.9M against.","Only routine items; no dissident proposals or director withhold votes reported."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233031,"accession_number":"0001932393-24-000033","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-04-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare reports Q1 2024 results: revenue flat organically, margins expand, reaffirms guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenues declined 1% to $4.6B; organic revenue approximately flat year-over-year.","Net income margin improved to 8.0% from 7.9%; Adjusted EBIT margin rose to 14.7% from 14.1%.","Diluted EPS increased to $0.81 from $0.41; Adjusted EPS rose to $0.90 from $0.85.","Cash from operations $419M vs $468M; free cash flow $274M vs $325M; repaid $150M debt.","Reaffirmed full-year 2024 guidance: ~4% organic revenue growth, Adjusted EPS $4.20-$4.35."],"consensus_eps_estimate":null,"consensus_eps_actual":0.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":4650000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233030,"accession_number":"0001932393-24-000027","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-04-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"GE HealthCare Imaging CEO Jan Makela resigns effective July 8, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jan Makela, Chief Executive Officer of Imaging, notified resignation on April 9, 2024.","He leaves to become CEO of a private non-competitor company; last day is July 8, 2024.","Company will evaluate internal and external candidates for the Imaging CEO role."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251196,"accession_number":"0001193125-24-068035","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-03-14T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"GEHC prices upsized secondary offering of 14M shares; selling stockholder may purchase additional shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering upsized to 14 million shares from previously announced 13 million.","GEHC will not receive any proceeds from the sale; selling stockholder is Morgan Stanley & Co. LLC.","Selling stockholder acquired shares via debt-for-equity exchange with General Electric prior to offering.","Closing expected March 15, 2024; underwriter has option to purchase additional shares by March 28.","Morgan Stanley acting as sole book-running manager for the offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251195,"accession_number":"0001193125-24-038569","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-02-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"GE HealthCare prices secondary offering of 13M shares at $82.25; GE to exchange debt for equity","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Secondary offering of 13,000,000 GEHC shares priced at $82.25 per share ($80.605 net of underwriting discount).","Company will not receive any proceeds; GE exchanging those shares for debt held by Morgan Stanley lenders.","Underwriters have a 30-day option to purchase additional GEHC shares at the offering price less discount.","Offering expected to close on February 21, 2024, subject to customary conditions.","Lead joint book-runners: Morgan Stanley, BofA, Citigroup, Evercore ISI, Goldman Sachs, J.P. Morgan, and others."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251194,"accession_number":"0001932393-24-000012","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q4 revenue $5.2B (+5% organic); Adj EPS $1.18; guides FY2024 Adj EPS $4.20-4.35","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $5.2B (+5% organic); net income $403M vs $554M; Adj EBIT margin 16.1% vs 17.1%.","FY 2023 revenue $19.6B (+8% organic); net income $1.6B; Adj EPS $3.93 vs $4.63 prior year.","Free cash flow Q4 $956M; repaid $850M debt in Q4 and $150M in Jan 2024.","FY2024 guidance: organic rev ~4% growth, Adj EBIT margin 15.6-15.9%, Adj EPS $4.20-4.35, FCF ~$1.8B.","Segment: Imaging +4% organic, Ultrasound -2%, Patient Care +4%, Pharma Diagnostics +23%."],"consensus_eps_estimate":null,"consensus_eps_actual":3.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":19552000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251192,"accession_number":"0001932393-24-000017","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K/A","filed_at":"2024-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q4 rev $5.2B (+5% organic), adj EPS $1.18; FY2024 adj EPS guide $4.20-$4.35","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $5.2B, up 5% organic YoY; net income $403M ($0.88 EPS) vs $554M ($1.21) prior year.","Adjusted EBIT margin 16.1% in Q4, flat vs standalone prior year; full year adj EBIT margin 15.1% vs 14.5% standalone prior year.","Full year revenue $19.6B (+7% reported, +8% organic); orders book-to-bill 1.03x.","2024 guidance: organic rev growth ~4%, adj EBIT margin 15.6%-15.9%, adj EPS $4.20-$4.35, FCF ~$1.8B.","Repaid $850M debt in Q4, $150M in Jan 2024; announced agreement to acquire MIM Software (no value disclosed)."],"consensus_eps_estimate":null,"consensus_eps_actual":3.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":19552000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251191,"accession_number":"0001932393-24-000015","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K/A","filed_at":"2024-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q4 revenue $5.2B (+5% organic); FY24 guided adj EPS $4.20-$4.35","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $5.2B (+5% organic YoY); net income $403M, adj EPS $1.18; adj EBIT margin 16.1%.","Full-year 2023 revenue $19.6B (+8% organic); adj EPS $3.93; operating cash flow $2.1B.","Segment: Imaging +4%, Ultrasound -2%, Patient Care +4%, Pharma Diagnostics +23% organic.","FY2024 guidance: organic rev growth ~4%; adj EBIT margin 15.6%-15.9%; adj EPS $4.20-$4.35; FCF ~$1.8B.","Repaid $850M debt in Q4 and $150M in Jan 2024; announced agreement to acquire MIM Software (no terms disclosed)."],"consensus_eps_estimate":null,"consensus_eps_actual":3.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":19552000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251193,"accession_number":"0001932393-24-000006","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2024-02-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"GE HealthCare Chief People Officer Betty Larson to resign effective March 21, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Betty D. Larson notified the Company on Jan 31, 2024 of her resignation as Chief People Officer.","Her last day with GE HealthCare will be March 21, 2024.","No successor or interim appointment has been announced in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268768,"accession_number":"0001932393-23-000133","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-12-15T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"GE HealthCare enters $1.0B 364-day revolver, terminates prior facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $1.0B unsecured revolving credit facility matures Dec 11, 2024, with Citibank as agent.","Borrowings available in USD and EUR at SOFR or EURIBOR plus margin tied to debt ratings.","Prior $1.0B 364-day facility dated Nov 4, 2022 terminated Dec 13, 2023 without penalty.","Credit agreement includes customary covenants (leverage ratio, liens, subsidiary indebtedness) and events of default."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268767,"accession_number":"0001932393-23-000124","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-10-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q3 revenue +6% organic; raises low end of adjusted EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4.8B, up 5% reported and 6% organic YoY; net income $375M vs $487M.","Adjusted EPS $0.99 vs standalone adjusted $0.87 (+14%); GAAP EPS $0.83 vs $1.07.","Adjusted EBIT margin 15.4% (+120 bps vs standalone 14.2%); free cash flow $570M (+$22M YoY).","Full-year adjusted EPS raised to $3.75-$3.85 (prior $3.70-$3.85); organic growth 6%-8%.","Imaging +5%, Ultrasound -1%, Patient Care Solutions +9%, Pharmaceutical Diagnostics +13%."],"consensus_eps_estimate":null,"consensus_eps_actual":2.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":14346000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":285878,"accession_number":"0001932393-23-000111","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-07-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q2 revenues up 9% organically; raises FY2023 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4.8B, +7% reported, +9% organic; organic orders +6%.","Net income $418M ($0.91 EPS) vs $485M ($1.04) prior year; adjusted EPS $0.92 vs $1.15.","Imaging revenue +9% organic to $2.6B; Pharmaceutical Diagnostics +20% organic to $568M.","FY2023 guidance raised: organic revenue growth 6-8% (prior 5-7%); adjusted EPS $3.70-$3.85 (prior $3.60-$3.75).","Adjusted EBIT margin guidance 15.0%-15.5%, free cash flow conversion 85%+."],"consensus_eps_estimate":null,"consensus_eps_actual":1.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":9524000000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305805,"accession_number":"0001932393-23-000094","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-05-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"GE HealthCare shareholders elect 10 directors, approve say-on-pay at 2023 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 10 director nominees elected with >99% of votes cast (excluding broker non-votes) for each.","Advisory vote on executive compensation approved: 346.9M for, 10.5M against, 1.4M abstain.","Stockholders chose 1-year frequency for future say-on-pay votes; board adopts annual practice.","Ratification of Deloitte & Touche as auditor for FY2023: 396.1M for, 1.5M against, 0.5M abstain.","Quorum of 398.1M shares out of 454.6M outstanding represented at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305804,"accession_number":"0000950142-23-001385","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"GE HealthCare names James Saccaro as CFO effective June 1, replacing Helmut Zodl","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James Saccaro named CFO effective June 1, 2023, replacing Helmut Zodl.","Saccaro's base salary: $875,000; target bonus: 100% of base; LTI award: $3.8M.","Saccaro joins from Baxter International, where he served as EVP and CFO since 2015.","Helmut Zodl transitions to Global Vice President, Special Projects and TSA Separation.","One-time sign-on: $350k cash plus $3.5M in RSUs; potential make-whole up to $3M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305803,"accession_number":"0001932393-23-000086","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-04-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q1 revenue up 12% organic; adjusted EPS $0.85; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4.7B, +8% reported, +12% organic; strong across all segments: Imaging, Ultrasound, PCS, PDx.","Net income attributable $372M; adjusted EBIT $664M, margin 14.1% (+30bps); adjusted EPS $0.85 vs $0.96.","Cash from ops $468M, free cash flow $325M; FY guidance: organic revenue growth 5-7%, adj. EPS $3.60-$3.75.","Board declares dividend $0.03/share; FY adjusted EBIT margin guided 15.0-15.5%.","Segment margins: Imaging 7.7% (down), Ultrasound 24.1% (up), PCS 14.0% (up), PDx 27.8% (down)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":4707000000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325108,"accession_number":"0001932393-23-000041","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-03-24T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"GE HealthCare adopts new severance plan for CEO and leadership team; boosts change-in-control benefits.","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO severance: 2.0x base + 2.0x bonus (non-CIC) or 2.99x each (CIC within 2 years); benefits for 24/36 months.","Leadership team: 1.0x base + 1.0x bonus (non-CIC) or 2.0x each (CIC); benefits for 12/24 months.","Effective April 1, 2023; replaces prior GE HealthCare US Executive Severance Plan.","Severance contingent on signing release with non-compete, non-solicit, non-disparagement.","Committee retains discretion to amend or terminate the plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325107,"accession_number":"0001932393-23-000037","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-03-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"GE HealthCare grants 2023 equity awards to CEO and NEOs; CEO receives 39,425 RSUs, 109,994 options, 70,683 PSUs","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Peter Arduini receives 39,425 RSUs, 109,994 stock options, and 70,683 PSUs under 2023 LTIP.","NEO Helmut Zodl receives 9,960 RSUs, 27,788 options, and 17,856 PSUs.","NEO Jan Makela receives 9,130 RSUs, 25,472 options, and 16,368 PSUs.","PSUs vest over 3 years based on financial goals and relative TSR; RSUs and options vest over 3.5 years.","Awards subject to non-solicitation, non-competition, and clawback provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325106,"accession_number":"0001932393-23-000031","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-02-24T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"GE HealthCare forms JV with Sinopharm subsidiary CMDC for China medical equipment","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["JV with China National Medical Device Co. (CMDC), a Sinopharm unit, to develop, manufacture, and commercialize medical equipment.","Initially focused on non-premium CT and general imaging ultrasound for primary care and rural health in China.","Subject to regulatory approvals in China; no financial terms disclosed.","Builds on existing JV relationship through Hangwei, formed in 1991."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325105,"accession_number":"0001932393-23-000012","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-02-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"GE HealthCare grants one-time equity awards to ~8,200 leaders; CEO gets 21,425 RSUs & 188,127 options","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Founders Grants of RSUs and stock options approved for ~8,200 leaders, including CEO and NEOs, post-spin-off.","CEO Peter J. Arduini receives 21,425 RSUs and 188,127 options; Helmut Zodl receives 5,356 RSUs and 47,031 options; Jan Makela receives 4,910 RSUs and 43,112 options.","Awards vest 50% on Feb 1, 2025 and 50% on Feb 1, 2026; unvested shares forfeited on termination except for death, disability, or business transfer.","Committee also adopts One GE HealthCare Annual Bonus Plan providing cash incentives tied to financial, strategic, and operational metrics.","Approximately 7,500 recipients not regularly receiving equity get grants based on salary; executive officers get grants based on LTI target."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325104,"accession_number":"0001932393-23-000007","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-01-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GE HealthCare Q4 revenue $4.9B, adj EPS $1.31; FY23 adj EPS guidance $3.60-$3.75","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $4.9B (+8% reported, +13% organic); net income $554M, EPS $1.21, adjusted EPS $1.31.","FY22 revenue $18.3B (+4% reported, +7% organic); net income $1.9B, EPS $4.18, adjusted EPS $4.63.","FY23 guidance: organic revenue growth 5-7%, adj EBIT margin 15.0-15.5%, adj EPS $3.60-$3.75, FCF conversion 85%+.","Cash from operations $2.1B, free cash flow $1.8B for FY22; cash conversion 111%.","Announced agreement to acquire IMACTIS to strengthen interventional guidance capabilities."],"consensus_eps_estimate":null,"consensus_eps_actual":4.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":18341000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":325103,"accession_number":"0001932393-23-000004","cik":1932393,"company_name":"GE HealthCare Technologies Inc.","ticker":"GEHC","form_type":"8-K","filed_at":"2023-01-10T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"GE HealthCare preliminary Q4 revenue ~$4.9B (+7% YoY); 2023 organic growth guidance 5-7%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2022 revenue ~$4.9B, up ~7% YoY; organic revenue growth ~12% YoY.","Full-year 2022 revenue ~$18.3B, up ~4% YoY; organic revenue growth ~7% YoY.","Full-year 2022 adjusted EBIT above outlook; free cash flow toward low end of guidance.","2023 outlook: organic revenue growth 5-7%; adjusted EBIT margin 15.0-15.5% (up 50-100 bps).","2023 free cash flow conversion guidance of 85%+."],"consensus_eps_estimate":null,"consensus_eps_actual":4.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":18341000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":28753710189.18128,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-01-10T23:59:59+00:00|325103"}